Novel 3-hydroxy-3-methylaglutaryl-Coenzyme A (HMG-CoA) reductase inhibitors, which are useful as antihypercholesterolemic agents and are represented by the following general structural formulae (I) and (II)
and pharmaceutically acceptable salts of the compound (II) ir which Z is hydrogen are disclosed.
                            本发明公开了新型 3-羟基-3-甲基戊二酰
辅酶 A(
HMG-CoA)还原酶
抑制剂,该
抑制剂可用作抗
胆固醇药物,由以下结构通式(I)和(II)以及 Z 为氢的化合物(II)的药学上可接受的盐表示。